<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1649">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04367545</url>
  </required_header>
  <id_info>
    <org_study_id>2020/0094/OB</org_study_id>
    <nct_id>NCT04367545</nct_id>
  </id_info>
  <brief_title>Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic</brief_title>
  <acronym>MolCOVID</acronym>
  <official_title>Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Rouen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Rouen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to develop and validate a molecular diagnostic strategy
      (RT-ddPCR multiplex) of COVID-19 based on a saliva sample and alternative to the RT-qPCR
      method, in order to :

        1. to compensate for the risk of a shortage of diagnostic kits, reagents and materials
           necessary for molecular diagnosis;

        2. to increase the molecular diagnostic capacity of COVID-19 at the Rouen University
           Hospital;

        3. and to have a method compatible with screening extended to populations at risk.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 16, 2020</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">July 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of positive patient using saliva method compared to number of positive patient using standard method</measure>
    <time_frame>One hour</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of negative patient using saliva method compared to number of negative patient using standard method</measure>
    <time_frame>One hour</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>COVID</condition>
  <condition>RT-ddPCR Multiplex</condition>
  <arm_group>
    <arm_group_label>Patient with COVID-19 infection suspicion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient with COVID-19 infection suspicion are tested using standard diagnosis method</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Saliva collection</intervention_name>
    <description>Saliva collection will be done in addition to standard diagnosis collection (nasopharyngeal collection using swab)</description>
    <arm_group_label>Patient with COVID-19 infection suspicion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Person aged over 18 years presenting to the COVID-19 consultation of the Rouen
             University Hospital for screening

          -  Person affiliated to a social security scheme

        Exclusion Criteria:

          -  Person objecting to participation in the research after reading information

          -  Person under the protection of justice,

          -  Person deprived of their liberty by administrative or judicial decision (guardianship,
             curatorship, etc.)

          -  Patient under guardianship or curatorship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thierry FREBOURG, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rouen University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thierry FREBOURG, Pr</last_name>
    <phone>+3323288</phone>
    <phone_ext>8265</phone_ext>
    <email>thierry.frebourg@chu-rouen.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julien BLOT</last_name>
    <email>julien.blot@chu-rouen.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rouen University Hospital</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thierry FREBOURG, Pr</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>April 27, 2020</study_first_submitted>
  <study_first_submitted_qc>April 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 29, 2020</study_first_posted>
  <last_update_submitted>June 5, 2020</last_update_submitted>
  <last_update_submitted_qc>June 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

